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ABSTRACT
Manipulation of the reproductive tract can cause in-
flammatory processes in the endometrium and release 
of cytokines and prostaglandins. It has been shown that 
PGF2α has direct negative effects on embryonic survival 
and development. Treatment with nonsteroidal antiin-
flammatory drugs (e.g., ibuprofen lysinate, flunixin me-
glumine) might improve pregnancy rates after embryo 
transfer in recipient heifers. The primary objective of 
this study was to evaluate the effect of a nonsteroidal 
antiinflammatory drug on reproductive performance in 
lactating dairy cows when administered at the time of 
first-service artificial insemination (AI) based on the 
hypothesis that uterine manipulation during AI might 
be similarly intense compared with embryo transfer 
in its effect on prostaglandin release. A total of 970 
cows (333 primiparous and 637 multiparous) from 17 
Holstein dairy farms were enrolled. On the day of first 
AI, cows were randomly allocated to 1 of 3 treatment 
groups. Cows of group 1 received 1.4 mg/kg of body 
weight (BW) of carprofen subcutaneously immediately 
after AI (SC group). In group 2, 1.4 mg/kg of BW 
of carprofen was administered into the uterus using 
a sterile disposable catheter 12 to 24 h after AI (IU 
group). Animals of group 3 remained as untreated 
controls. First AI conception rate was similar for the 
SC group (42.2%) compared with the untreated control 
group (45.1%). A binary logistic regression model for 
the odds of conception at first AI revealed a negative 
effect of an intrauterine administration of carprofen 
on conception rate (38.3%). Cows allocated to the IU 
group had a lower likelihood of being pregnant within 
200 d in milk than cows in the control group. In sum-
mary, subcutaneous treatment with the nonsteroidal 
antiinflammatory drug carprofen at the time of AI did 
not influcence conception rate, whereas an intrauterine 
administration of carprofen 12 to 24 h after first AI 
had a negative effect on first-service conception rate in 
lactating dairy cows.
Key words:  uterine manipulation, nonsteroidal anti-
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INTRODUCTION
Reproductive performance in dairy cows is influenced 
by multiple factors such as transition cow management, 
metabolic and udder health, lameness, estrus detection, 
semen handling, and use of synchronization protocols 
(Lucy, 2001; Caraviello et al., 2006).
Manipulation of the reproductive tract can represent a 
trauma to the uterine endometrium causing subsequent 
inflammatory processes; that is, release of chemical me-
diators such as cytokines and prostaglandins. A 2-min 
uterine manipulation increased plasma concentration 
of 13,14-dihydro-15 keto prostaglandin 2α (PGFM) in 
cows at 35 d postpartum (Wann and Randel, 1990). 
In a more recent study the intensity of uterine ma-
nipulation necessary to conduct embryo transfer (ET) 
was scored on a scale from 1 (i.e., transfer requiring 
minimal manipulation of the genital tract) to 3 (i.e., 
transfer requiring extreme manipulation of the genital 
tract). Concentrations of PGF2α were already increased 
following minimal manipulation during ET (Scenna et 
al., 2005). Both in vivo and in vitro studies provided 
sound evidence that PGF2α has direct negative effects 
on embryonic survival or development (Buford et al., 
1996; Seals et al., 1998).
Nonsteroidal antiinflammatory drugs (NSAID) block 
the synthesis of prostaglandins including PGF2α via in-
hibition of the 2 isoforms of the enzyme cyclooxygenase 
(COX, EC 1.14.99.1), COX-1 and COX-2 (Anderson et 
al., 1990). These enzymes are the essential catalysts at 
the beginning of the synthesis of prostaglandins. Inhibi-
tion of PGF2α secretion through NSAID has been dem-
onstrated to increase reproductive performance after 
ET. Pregnancy rates after ET were higher in recipient 
heifers receiving either 5 mg of ibuprofen lysinate (82 
vs. 56%) or 830 mg of flunixin meglumine (FM, 65.3 
vs. 60.2%) compared with untreated control animals 
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(Elli et al., 2001; Scenna et al., 2005). Although the 
timing of treatment relative to ET (immediately before 
vs. after transfer) did not affect reproductive perfor-
mance, the difference in pregnancy rates was greater 
(64.2 vs. 53.5%) for lower quality embryos. The authors 
concluded that developmentally compromised embryos 
were most susceptible to deleterious effects of PGF2α 
compared with high quality embryos (Scenna et al., 
2005).
The suppressive effect of FM on PGF2α synthesis 
reached its maximum 4 h after application and per-
sisted for up to 8 h (Thun et al., 1993). The same 
authors suggested repeating administration every 4 to 
6 h to ensure inhibition of prostaglandin synthesis for 
a longer period.
Carprofen also had antiinflammatory effects without 
selectivity in sheep (Cheng et al., 2002) and had an 
extended elimination half-life (ranging from 44.5 to 64. 
6h) compared with those reported for other NSAID such 
as FM (Ludwig et al., 1989). Commercially available 
products contain a racemic mixture of 2 enantiomeric 
isoforms of carprofen. Research in vitro demonstrated 
that the S(+)-enantiomer is more selective for COX-2 
than the R(−)-enantiomer of carprofen (Ricketts et al., 
1998).
Although some evidence exists suggesting that uterine 
manipulation is associated with the amount of PGF2α 
secreted (Wann and Randel, 1990; Scenna et al., 2005), 
information is lacking on how uterine manipulation 
during AI affects concentrations of PGFM or PGF2α.
We hypothesize that uterine manipulation during AI 
and ET can be similarly intense in its effect on pros-
taglandin release because in both cases an instrument 
is passed through the cervical canal. Therefore, the 
overall objective of this study was to evaluate the effect 
of a COX inhibitor drug (carprofen) on reproductive 
performance in lactating dairy cows when administered 
at the time of first service. Specifically, we set out to 
(1) compare first-service conception rates between cows 
treated subcutaneously with a long-acting NSAID and 
untreated control cows, and (2) study the effect of 
NSAID administered into the uterus 12 to 24 h after 
AI on first-service conception rate.
MATERIALS AND METHODS
All procedures in this trial were conducted according 
to the International Cooperation on Harmonization of 
Technical Requirements for Registration of Veterinary 
Medicinal Products (2000) regulations relating to Good 
Clinical Practice and Clinical Trials (GCP). A total of 
970 cows (333 primiparous and 637 multiparous) from 17 
Holstein dairy farms located in Brandenburg, Germany, 
were enrolled between October and December 2007. 
The farms had been identified in advance to ensure a 
valid test permit for each herd and informed consent 
of the farm manager. Inclusion criteria were herd size 
(>100 cows), participation in the German Dairy Herd 
Improvement Organization (Landeskontrollverband 
Brandenburg, Waldsieversdorf, Germany), all breedings 
through AI, and an electronic record-keeping system. 
The herds ranged from 180 to 630 milking cows and 
the rolling herd averages were about 10,000 kg of milk 
per cow per year. All lactating dairy cows were housed 
in freestall facilities and milked twice a day. Repro-
ductive management varied among farms. All dairies 
relied on estrus detection for their breedings and were 
serviced by an AI technician employed by one company 
(Rinderproduktion Berlin-Brandenburg GmbH, Groß 
Kreutz, Germany). Synchronization protocols were not 
implemented. Seven AI technicians were involved in the 
study, each servicing from 1 to 3 study sites.
On the day of first insemination, cows were randomly 
allocated to 1 of 3 treatment groups using a random 
treatment allocation plan generated before the ini-
tiation of the trial using a random number generator 
(Excel 2003, Microsoft Corp., Redmond, WA). Each 
of the AI technicians was supplied with an allocation 
plan for each of their client farms. Cows of group 1 re-
ceived 1.4 mg/kg of BW of carprofen (Rimadyl, Pfizer 
Animal Health, Berlin, Germany) subcutaneously (SC, 
n = 325) immediately after AI. In group 2, 1.4 mg/kg 
of BW of carprofen was administered into the uterus 
using a sterile disposable catheter 12 to 24 h after AI 
(IU, n = 317). Animals of group 3 (CON, n = 327) 
remained as untreated controls. Treatment was not 
documented for 1 cow.
Pregnancy was diagnosed on d 39 to 48 after AI by 
transrectal palpation carried out by a veterinarian who 
was unaware of the treatment allocation. This diagnosis 
was confirmed at approximately 100 d after insemina-
tion. Reproductive performance was characterized by 
first AI conception rate (number of cows pregnant after 
first AI divided by number of cows inseminated × 100) 
as the primary outcome variable (i.e., only for animals 
detected in estrus and inseminated) and days to first 
AI.
Furthermore, days to pregnancy, all-service concep-
tion rate (number of cows pregnant after all AI divided 
by number of cows inseminated × 100), and pregnancy 
rate at 200 DIM (number of cows documented to be 
pregnant by 200 DIM divided by number of cows 
enrolled × 100) were calculated from 11 farms for a 
subset of cows (n = 543). All treatments and diagnoses 
were documented on case report forms (CRF). At the 
end of the study, CRF were checked for compliance. 
Cows with incomplete treatments were retrospectively 
withdrawn from the study. For quality assurance of raw 
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data and CRF, an online monitoring tool (DrNet Study 
Monitor, Berlin, Germany) was used. Sample size for 
this study (statistical power 80%) was calculated as 
320 cows per group for an estimated first AI conception 
rate of 35% to find proportions of <27% and >43% as 
significant (P < 0.05).
Statistical Analysis
Data were analyzed using SPSS (version 16.0, SPSS 
Inc., Munich, Germany). Binary logistic regression 
models were calculated for the risk of conception at first 
AI as the primary outcome variable. Survival analysis 
for the probability of pregnancy within 200 DIM was 
performed using Cox regression, censoring cows that 
were not pregnant. For logistic regression models as 
well as for survival analysis, group (1 = SC, 2 = IU, 3 
= CON), parity class (0 = primiparous, 1 = multipa-
rous), AI technician, and herd were included as fac-
tors. Group CON was chosen as reference for covariate 
group. Adjusted odds ratios, hazard ratios, confidence 
intervals, and P-values are reported. For logistic regres-
sion as well as for survival analyses, CI was set at 95%. 
For all statistical analyses level of significance was set 
at α = 0.05.
RESULTS AND DISCUSSION
We hypothesized that the administration of a COX 
inhibitor drug (carprofen) at the time of AI could have 
a similarly positive effect on reproductive performance 
of dairy cows as has been demonstrated for recipient 
heifers after ET (Elli et al., 2001; Scenna et al., 2005). 
The results of this study do not provide any evidence of 
a positive effect of the NSAID carprofen on conception 
rates in lactating dairy cows administered s.c. at the 
time of AI.
For the analysis of the primary outcome variable, 
964 (99.4%) cows could be used (Table 1). Six cows 
(0.6%) had to be excluded from the analyses because 
of missing treatment information (n = 1) or protocol 
noncompliance (n = 5). Median time from calving to 
first AI for all cows enrolled was 69 d (interquartile 
range: 56.0–91.0). For the subset of farms (n = 11) 
overall submission rate for AI was 23.7 ± 7.7%.
First AI conception rate was similar for the SC group 
(42.2%, P = 0.45) and numerically lower in the IU group 
(38.3%, P = 0.08) compared with the untreated control 
group (45.1%; Figure 1). A binary logistic regression 
model for the risk of conception at first AI revealed a 
negative effect of intrauterine administration of carpro-
fen on conception rate (Table 2; P = 0.08). Because we 
did not utilize a fourth group of cows treated with an 
intrauterine infusion of a control fluid at the same time 
as the carprofen was infused (i.e., 12 to 24 h after AI), 
it remains unclear if this negative effect was caused 
by toxic properties of the NSAID itself or the infusion 
process of a fluid in general. It is possible that the 
carprofen in the pharmacological formulation used was 
not absorbed into the endometrium and thus could not 
prevent uterine prostaglandin release. Therefore, the 
additional uterine manipulation necessary to adminis-
ter the carprofen into the uterus of the cows in the IU 
group could have caused prostaglandin release, disrupt-
ing preimplantation processes or exerting an embryo 
toxic effect (Hockett et al., 2004; Scenna et al., 2004). 
Furthermore, it is possible that the procedure of pass-
ing a catheter for administering the fluid into the uterus 
1 d after insemination caused inflammation or entry 
of pathogens detrimental to fertility. Findings from a 
previous trial, however, studying the effect of collecting 
endometrial samples with the cytobrush technique 4 h 
after AI on first AI conception rate do not support this 
hypothesis (Kaufmann et al., 2009). First AI concep-
tion rate was 43.3% for cows (n = 201) examined with 
the cytobrush technique and 41.7% for cows (n = 103) 
with no sample taken after AI (P > 0.05). The results 
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Table 1. Descriptive data of reproductive performance parameters for cows treated with 1.4 mg of carprofen/kg of BW subcutaneously or into 









Median days to first AI (IR1) 67.0 70.0 69.5 
(55.0–90.0) (57.0–95.0) (57.0–89.0)
Median days open (IR) 71.0 74.5 74.0 
(55.0–96.0) (58.3–102.8) (58.0–99.5)
First AI conception rate, % (95% CI) 42.2 38.3a 45.1b 
(36.6–47.4) (32.8–43.6) (39.5–50.3)
Pregnancy rate at 200 d, % (95% CI) 86.6 76.4 87.7 
(81.1–91.5) (69.5–82.5) (82.5–92.3)
a,bValues with different superscripts in the same row differ (P = 0.08).
1IR = interquartile range.
of the 2 studies, however, are not directly comparable 
because timing between AI and passing the catheter 
was different (4 h vs. 12 to 24 h).
Primiparous cows were significantly more likely to 
become pregnant than multiparous cows (P < 0.01) as 
has been reported previously (Tenhagen et al., 2004). 
Conception rate after first AI was affected by a herd × 
AI technician interaction (P = 0.04).
Descriptive reproductive performance traits derived 
from outcomes of second and greater inseminations up 
to 200 DIM could be obtained from 11 farms providing 
a total of 543 cows. Table 3 shows the results of the 
survival analyses (Cox regression) for the odds of preg-
nancy within 200 DIM for this subset of cows. Group 
CON and <55 median days at first AI were chosen as 
the reference factors for treatment group and interval 
to first AI, respectively. Again, cows allocated to the IU 
group had a lower likelihood of being pregnant within 
200 DIM than cows in the control group (P < 0.01). 
Besides treatment group, the hazard for pregnancy was 
affected by median days to AI and parity, but was not 
affected by herd and technician. The odds for pregnancy 
were lower for treated cows compared with untreated 
control cows and higher for primiparous cows compared 
with multiparous cows.
Pregnancy diagnosis (PD) was performed once on d 
39 to 48 after AI by transrectal palpation. A second PD 
to monitor pregnancy losses between first PD and 100 
DIM was not conducted. Of cows diagnosed as preg-
nant at first PD (n = 244), only 11 cows (2.9%) were 
re-inseminated between 40 and 100 DIM. These data 
indicate that pregnancy losses were not a predominant 
problem of the participating dairy farms.
Meloxicam treatment on d 15 after insemination de-
creased pregnancy rates in heifers significantly (Erdem 
and Guzeloglu, 2008). The authors hypothesized that a 
longer inhibition of prostaglandin H synthase activity 
interfered with the preimplantation process. Our data 
demonstrate that NSAID administered s.c. at the time 
of AI do not affect reproductive performance. Cows 
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Figure 1. Proportion of pregnant cows for cows treated with carprofen subcutaneously (SC) or into the uterus (IU) and untreated (CON) 
control cows over 200 d of lactation.
of the control group (45.1%) and cows treated subcu-
taneously with carprofen (42.2%) had similar first AI 
conception rates.
Long-acting NSAID such as carprofen and meloxi-
cam have been recommended as additional treatments 
for cows with clinical mastitis. Several positive effects 
have been demonstrated such as improved general clini-
cal condition by effective antipyrexia and restoration 
of reticulorumen motility in cows with Escherichia 
coli mastitis (Vangroenweghe et al., 2005) and a lower 
SCC and a reduced risk of removal from the herd (Mc-
Dougall et al., 2009). Our data support evidence that 
carprofen administered s.c. at the time of breeding for 
the treatment of inflammatory diseases (i.e., clinical 
mastitis or lameness) does not compromise reproduc-
tive performance.
CONCLUSIONS
First-service conception rate was not influenced by 
the NSAID carprofen administered s.c. at the time of 
first AI. Intrauterine administration of carprofen 12 
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Table 2. Results of binary logistic regression analysis for the risk of conception after first AI in cows treated 
with 1.4 mg of carprofen/kg of BW subcutaneously or into the uterus and untreated control cows including 
treatment group, median days to AI, parity, AI technician, and herd as covariates (n = 964) 
Factor





Treatment group1   0.22
 Control Referent
 Subcutaneous 0.89 0.65–1.22 0.48
 Intrauterine 0.75 0.55–1.04 0.08
Median days to AI   0.13
 <55 DIM Referent
 56–78 DIM 1.03 0.73–1.46 0.86
 79–101 DIM 1.31 0.87–1.95 0.19
 >101 DIM 1.50 1.00–2.25 0.05
Parity class2 0.62 0.48–0.82 <0.01
AI technician 0.77 0.59–1.01 0.06
Herd 0.91 0.81–1.01 0.07
Herd × AI technician 1.02 1.00–1.05 0.04
Constant 3.06  0.09
1Cows received 1.4 mg/kg of BW of carprofen subcutaneously immediately after AI, or into the uterus 12 to 
24 h after AI, or remained untreated.
2Parity class: 0 = primiparous, 1 = multiparous.
Table 3. Results of the survival analyses (Cox regression) for the odds of pregnancy within 200 DIM in cows 








Treatment group1   <0.01
 Control Referent
 Subcutaneous 0.96 0.76–1.21 0.73
 Intrauterine 0.68 0.53–0.87 <0.01
Median days to AI   <0.01
 <55 DIM Referent
 56–78 DIM 0.59 0.44–0.79 <0.01
 79–101 DIM 0.49 0.36–0.67 <0.01
 >101 DIM 0.26 0.19–0.36 <0.01
Parity class2 0.80 0.66–0.98 0.03
AI technician 0.99 0.80–1.23 0.93
Herd 1.00 0.92–1.08 0.91
Herd × AI technician 1.00 0.98–1.02 0.93
1Cows received 1.4 mg/kg of BW of carprofen subcutaneously immediately after AI or into the uterus 12 to 24 
h after AI, or remained untreated.
2Parity class: 0 = primiparous, 1 = multiparous.
to 24 h after first AI, however, tended (P > 0.08) to 
have a negative effect on first-service conception rate. 
Additional research is warranted to evaluate the effect 
of NSAID for the treatment of cows diagnosed with 
subclinical endometritis before AI.
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